These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 166190)

  • 21. Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
    Ravault JP; Courot M; Garnier D; Pelletier J; Terqui M
    Biol Reprod; 1977 Sep; 17(2):192-7. PubMed ID: 578119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
    Kalbermann LE; Machiavelli GA; De Nicola AF; Weissenberg LS; Burdman JA
    J Endocrinol; 1980 Nov; 87(2):221-4. PubMed ID: 7430920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphology and anatomic localization of renal microneoplasms and proximal tubule dysplasias induced by four different estrogens in the hamster.
    Goldfarb S; Pugh TD
    Cancer Res; 1990 Jan; 50(1):113-9. PubMed ID: 2152770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine restores angiotensin II response in pituitary hyperplasia.
    González Iglesias A; Díaz-Torga G; Piroli G; Achával-Zaia R; De Nicola AF; Libertun C; Becu-Villalobos D
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):67-74. PubMed ID: 10940485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
    Sumi C; Yokoro K; Matsushima R
    Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G; Masala A; Alagna S; Devilla L
    IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
    [No Abstract]   [Full Text] [Related]  

  • 27. Superoxide dismutase and catalase levels during estrogen-induced renal tumorigenesis, in renal tumors and their autonomous variants in the Syrian hamster.
    McCormick ML; Oberley TD; Elwell JH; Oberley LW; Sun Y; Li JJ
    Carcinogenesis; 1991 Jun; 12(6):977-83. PubMed ID: 2044204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats.
    Piroli GG; Torres A; Pietranera L; Grillo CA; Ferrini MG; Lux-Lantos V; Aoki A; De Nicola AF
    Neuroendocrinology; 2000 Aug; 72(2):80-90. PubMed ID: 10971143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of hepatic tumors by diethylstilbestrol alone or in synergism with n-nitrosobutylurea in castrated male WF rats.
    Sumi C; Yokoro K; Matsushima R
    J Natl Cancer Inst; 1983 May; 70(5):937-42. PubMed ID: 6573538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
    Mashiter K; Adams E; Beard M; Holley A
    Lancet; 1977 Jul; 2(8030):197-8. PubMed ID: 69814
    [No Abstract]   [Full Text] [Related]  

  • 31. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
    Lloyd RV
    Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen-induced renal carcinogenesis in the hamster: ultrastructural and hormonal studies of the pars intermedia before and after withdrawal of oestrogen.
    Ismail AA; Saluja PG; Thody AJ; Hamilton JM
    Z Mikrosk Anat Forsch; 1983; 97(2):343-56. PubMed ID: 6636971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early effects of stilboestrol on growth hormone and prolactin secretion and on pituitary mitotic activity in the male rat.
    Lloyd HM; Meares JD; Jacobi J
    J Endocrinol; 1973 Aug; 58(2):227-31. PubMed ID: 4726322
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antiprogestagen RU486 on both natural and prolactin-induced morphological luteolysis in rat.
    Sánchez-Criado JE; Ruiz A; Tébar M
    Rev Esp Fisiol; 1994 Jun; 50(2):97-102. PubMed ID: 7800920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretory and mitotic response of the male rat pituitary gland to repeated doses of oestrogen.
    Lloyd HM; Meares JD; Jacobi J
    Int J Cancer; 1973 Jan; 11(1):90-4. PubMed ID: 4790838
    [No Abstract]   [Full Text] [Related]  

  • 37. Light deprivation retards the growth of the diethylstilbesterol-induced renal tumor in hamsters.
    Logan JL; Benson B
    Growth Dev Aging; 1990; 54(1-2):39-43. PubMed ID: 2210920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological, histochemical and ultrastructural observations of diethylstilbestrol-induced kidney tumors in the Syrian golden hamster.
    Llombart-Bosch A; Peydro A
    Eur J Cancer (1965); 1975 Jun; 11(6):403-12. PubMed ID: 170117
    [No Abstract]   [Full Text] [Related]  

  • 39. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
    Hatala MA; Powers CA
    Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.